Microsatellite instability as a predictive factor for immunotherapy in malignant melanoma-Reference-Cited by-同舟云学术

Microsatellite instability as a predictive factor for immunotherapy in malignant melanoma

Published:2016-08 Issue: Volume:93 Page:74-76
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Kubecek Ondrej,Trojanova Petronela,Molnarova Veronika,Kopecky Jindrich

Publisher

Elsevier BV

Subject

General Medicine

Reference39 articles.

1. A national cancer institute workshop on microsatellite instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer;Boland;Cancer Res,1998

2. Exomics and immunogenics: bridging mutational load and immune checkpoints efficacy;Champiat;Oncoimmunology,2014

3. Colorectal cancers with microsatellite instability display mRNA expression signatures characteristic of increased imunogenicity;Banerjea;Mol Cancer,2004

4. A TGF betaRII frameshift-mutation-derived CTL epitope recognized by HLA-A2-restricted CD8+ T cells;Saeterdal;Cancer Immunol Immunother,2001

5. Frameshift-mutation-derived peptides as tumor-specific antigens in inherited and spontaneous colorectal cancer;Saeterdal;Proc Natl Acad Sci USA,2001

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Case report: Fast disease progression during adjuvant therapy with anti-PD-1 in stage III melanoma patients;Frontiers in Oncology;2024-08-01

2. Identification of a CpG-based signature coupled with gene expression as prognostic indicators for melanoma: a preliminary study;Scientific Reports;2024-03-04

3. Inhibition of ABL1 by tyrosine kinase inhibitors leads to a downregulation of MLH1 by Hsp70-mediated lysosomal protein degradation;Frontiers in Genetics;2022-10-20

4. Microsatellite Instability: From the Implementation of the Detection to a Prognostic and Predictive Role in Cancers;International Journal of Molecular Sciences;2022-08-05

5. HLA-I diversity and tumor mutational burden by comprehensive next-generation sequencing as predictive biomarkers for the treatment of non-small cell lung cancer with PD-(L)1 inhibitors;Lung Cancer;2022-08